Biotech vs. Shorts Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech vs. Shorts

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Gordon James who wrote (179)	8/25/1999 2:00:00 AM
From: Vector1	Read Replies (1) of 427

<<Coulter Pharmaceutical Reiterated `Sell' at Avalon>> Someone better remind these guys of the little boy who cried wolf. If the FDA accepts the application in the next week these guys are toast and they know it. By the way, the former chairperson of the BLA advisory committee that will consider Bexxar was chaired by Julie Voss. Julie Voss, who is extremely well regarded, has been a vocal and powerful advocate of Bexxar. The theme of this thread are companies that short sellers have tried to damage with false or misleading rumors and inuendo. I know there are some on this thread who I have great respect for who are not sold on CLTR, however, I would submit that (assuming the FDA accepts the BLA) that CLTR has been the most unfairly and malicously maligned biotech of 99. V1

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next